User menu

Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen

Bibliographic reference Lurquin, C. ; Théate, Ivan ; Lethé, Bernard ; De Plaen, Etienne ; Corbiere, Véronique ; et. al. Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen. In: The Journal of Experimental Medicine, Vol. 201, no. 2, p. 249-257 (2005)
Permanent URL
  1. J. Exp. Med., 201, 241 (2004)
  2. Fantini M. C., Becker C., Monteleone G., Pallone F., Galle P. R., Neurath M. F., Cutting Edge: TGF-  Induces a Regulatory Phenotype in CD4+CD25- T Cells through Foxp3 Induction and Down-Regulation of Smad7, 10.4049/jimmunol.172.9.5149
  3. Fallarino Francesca, Grohmann Ursula, Hwang Kwang Woo, Orabona Ciriana, Vacca Carmine, Bianchi Roberta, Belladonna Maria Laura, Fioretti Maria Cristina, Alegre Maria-Luisa, Puccetti Paolo, Modulation of tryptophan catabolism by regulatory T cells, 10.1038/ni1003
  4. Uyttenhove Catherine, Pilotte Luc, Théate Ivan, Stroobant Vincent, Colau Didier, Parmentier Nicolas, Boon Thierry, Van den Eynde Benoît J, Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase, 10.1038/nm934
  5. Munn D. H., Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes, 10.1172/jci200421583
  6. Lonchay C., van der Bruggen P., Connerotte T., Hanagiri T., Coulie P., Colau D., Lucas S., Van Pel A., Thielemans K., van Baren N., Boon T., Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen, 10.1073/pnas.0405743101
  7. Boon Thierry, Van den Eynde Benoit, Tumour immunology, 10.1016/s0952-7915(03)00010-4
  8. Dudley M. E., Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes, 10.1126/science.1076514
  9. Uyttenhove C., Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression, 10.1084/jem.157.3.1040
  10. Benitez R., Godelaine D., Lopez-Nevot M.A., Brasseur F., Jimenez P., Marchand M., Oliva M.R., Baren N., Cabrera T., Andry G., Landry C., Ruiz-Cabello F., Boon T., Garrido F., Mutations of the β2-microglobulingene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides, 10.1111/j.1399-0039.1998.tb03082.x
  11. Karanikas V., Lurquin C., Colau D., van Baren N., De Smet C., Lethe B., Connerotte T., Corbiere V., Demoitie M.-A., Lienard D., Dreno B., Velu T., Boon T., Coulie P. G., Monoclonal Anti-MAGE-3 CTL Responses in Melanoma Patients Displaying Tumor Regression after Vaccination with a Recombinant Canarypox Virus, 10.4049/jimmunol.171.9.4898
  12. Lennon G. P., Sillibourne J. E., Furrie E., Doherty M. J., Kay R. A., Antigen Triggering Selectively Increases TCRBV Gene Transcription, 10.4049/jimmunol.165.4.2020
  13. Davies Helen, Bignell Graham R., Cox Charles, Stephens Philip, Edkins Sarah, Clegg Sheila, Teague Jon, Woffendin Hayley, Garnett Mathew J., Bottomley William, Davis Neil, Dicks Ed, Ewing Rebecca, Floyd Yvonne, Gray Kristian, Hall Sarah, Hawes Rachel, Hughes Jaime, Kosmidou Vivian, Menzies Andrew, Mould Catherine, Parker Adrian, Stevens Claire, Watt Stephen, Hooper Steven, Wilson Rebecca, Jayatilake Hiran, Gusterson Barry A., Cooper Colin, Shipley Janet, Hargrave Darren, Pritchard-Jones Katherine, Maitland Norman, Chenevix-Trench Georgia, Riggins Gregory J., Bigner Darell D., Palmieri Giuseppe, Cossu Antonio, Flanagan Adrienne, Nicholson Andrew, Ho Judy W. C., Leung Suet Y., Yuen Siu T., Weber Barbara L., Seigler Hilliard F., Darrow Timothy L., Paterson Hugh, Marais Richard, Marshall Christopher J., Wooster Richard, Stratton Michael R., Futreal P. Andrew, Mutations of the BRAF gene in human cancer, 10.1038/nature00766
  14. J. Immunol., 163, 5211 (1999)
  15. Wang Helen Y, Lee Dean A, Peng Guangyong, Guo Zhong, Li Yanchun, Kiniwa Yukiko, Shevach Ethan M, Wang Rong-Fu, Tumor-Specific Human CD4+ Regulatory T Cells and Their Ligands, 10.1016/s1074-7613(03)00359-5
  16. Terabe Masaki, Matsui So, Park Jong-Myun, Mamura Mizuko, Noben-Trauth Nancy, Donaldson Debra D., Chen Wanjun, Wahl Sharon M., Ledbetter Steven, Pratt Bruce, Letterio John J., Paul William E., Berzofsky Jay A., Transforming Growth Factor-β Production and Myeloid Cells Are an Effector Mechanism through Which CD1d-restricted T Cells Block Cytotoxic T Lymphocyte–mediated Tumor Immunosurveillance : Abrogation Prevents Tumor Recurrence, 10.1084/jem.20022227
  17. Gorelik Leonid, Flavell Richard A., 10.1038/nm1001-1118
  18. Jonuleit Helmut, Schmitt Edgar, Kakirman Hacer, Stassen Michael, Knop Jürgen, Enk Alexander H., Infectious Tolerance : Human CD25+Regulatory T Cells Convey Suppressor Activity to Conventional CD4+T Helper Cells, 10.1084/jem.20020394